STOCK TITAN

Sylvamo Corporation (SLVM) Financials

SLVM
Trailing 12 months to June 30, 2026
Revenue $3.3B -7.1% YoY
Net Income $76.0M -65.1% YoY
EPS (Diluted) $1.87 -64.1% YoY
Free Cash Flow -$11.0M -105.7% YoY
Market Cap $1.4B as of Sep 12, 2026
Price / Sales 0.4x on $3.3B revenue, trailing 12 months to June 30, 2026
Price / Earnings 18.5x on $76.0M net income, trailing 12 months to June 30, 2026
Price / Book 1.5x on $955.0M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 12, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 7, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SLVM SEC filings page.

Sylvamo Corporation (SLVM) reported $3.3B in revenue over the twelve months to Jun 30, 2026, down 7.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SLVM FY2025

Sylvamo’s dominant mechanic is cyclical margin compression: lower sales and profitability sharply reduce cash available after capital reinvestment.

FY2025’s $132M net income produced only $44M of free cash flow, so accounting profit was not a good proxy for cash available after reinvestment. Operating cash flow of $268M against $224M of capital spending explains why cash conversion weakened even though the company remained profitable.

Revenue contracted to $3.35B while gross margin fell to 21.9%, indicating pressure on both top-line scale and per-dollar economics. Operating margin dropped to 7.5% from 12.0%; net margin fell to 3.9% from 8.0%, so profit compressed faster than sales, consistent with weaker operating absorption or mix.

Debt-to-equity eased from 0.9x to 0.8x while the current ratio remained near 1.5x, showing a less leveraged balance sheet despite weaker earnings. The $155M of buybacks and dividends exceeded $44M of free cash flow, meaning shareholder distributions were not funded by that year’s FCF alone.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 48 / 100
Financial Health Score 48/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Sylvamo Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
68

Sylvamo Corporation has an operating margin of 7.5%, meaning the company retains $7 of operating profit per $100 of revenue. This strong profitability earns a score of 68/100, reflecting efficient cost management and pricing power. This is down from 12.0% the prior year.

Growth
16

Sylvamo Corporation's revenue declined 11.2% year-over-year, from $3.8B to $3.4B. This contraction results in a growth score of 16/100.

Leverage
39

Sylvamo Corporation has a moderate D/E ratio of 0.79. This balance of debt and equity financing earns a leverage score of 39/100.

Liquidity
41

Sylvamo Corporation's current ratio of 1.50 indicates adequate short-term liquidity, earning a score of 41/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
42

While Sylvamo Corporation generated $268.0M in operating cash flow, capex of $224.0M consumed most of it, leaving $44.0M in free cash flow. This results in a low score of 42/100, reflecting heavy capital investment rather than weak cash generation.

Returns
81

Sylvamo Corporation earns a strong 13.7% return on equity (ROE), meaning it generates $14 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 81/100. This is down from 35.7% the prior year.

Altman Z-Score Safe
3.41

Sylvamo Corporation scores 3.41, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
5/9

Sylvamo Corporation passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
2.03x

For every $1 of reported earnings, Sylvamo Corporation generates $2.03 in operating cash flow ($268.0M OCF vs $132.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
5.12x

Sylvamo Corporation earns $5.12 in operating income for every $1 of interest expense ($251.0M vs $49.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$806.0M
YoY+1.5%
QoQ+6.8%
5Y CAGR+3.0%

Sylvamo Corporation generated $806.0M in revenue in Q2 2026. This represents an increase of 1.5% from the same quarter a year earlier. Against the prior quarter it is up 6.8%.

EBITDA
$57.0M
YoY-24.0%
QoQ+119.2%

Sylvamo Corporation's EBITDA was $57.0M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 24.0% from the same quarter a year earlier. Against the prior quarter it is up 119.2%.

Net Income
-$11.0M
YoY-173.3%
QoQ-266.7%

Sylvamo Corporation reported -$11.0M in net income in Q2 2026. This represents a decrease of 173.3% from the same quarter a year earlier. Against the prior quarter it is down 266.7%.

EPS (Diluted)
-$0.28
YoY-175.7%
QoQ-250.0%

Sylvamo Corporation earned -$0.28 per diluted share (EPS) in Q2 2026. This represents a decrease of 175.7% from the same quarter a year earlier. Against the prior quarter it is down 250.0%.

Cash & Balance Sheet

Free Cash Flow
-$23.0M
YoY-1050.0%
QoQ+61.0%

Sylvamo Corporation recorded an outflow of $23.0M in free cash flow in Q2 2026, representing a cash shortfall after capex. This represents a decrease of 1050.0% from the same quarter a year earlier. Against the prior quarter it is up 61.0%.

Cash & Debt
$123.0M
YoY+8.8%
QoQ-5.4%
5Y CAGR-8.1%

Sylvamo Corporation held $123.0M in cash against $843.0M in long-term debt as of Q2 2026.

Dividends Per Share
$0.45
YoY0.0%
QoQ0.0%

Sylvamo Corporation paid $0.45 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
40M
YoY-1.5%
QoQ+0.1%

Sylvamo Corporation had 40M shares outstanding in Q2 2026. This represents a decrease of 1.5% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Margins & Returns

Gross Margin
16.4%
YoY-3.0pp
QoQ-0.2pp
5Y change-24.9pp

Sylvamo Corporation's gross margin was 16.4% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 3.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.2 percentage points.

Operating Margin
1.7%
YoY-2.0pp
QoQ+3.7pp

Sylvamo Corporation's operating margin was 1.7% in Q2 2026, reflecting core business profitability. This is down 2.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.7 percentage points.

Net Margin
-1.4%
YoY-3.3pp
QoQ-1.0pp
5Y change-17.9pp

Sylvamo Corporation's net profit margin was -1.4% in Q2 2026, showing the share of revenue converted to profit. This is down 3.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.0 percentage points.

Return on Equity
-1.1%
YoY-2.7pp
QoQ-0.8pp
5Y change-6.2pp

Sylvamo Corporation's ROE was -1.1% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 2.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.

Capital Allocation

Share Buybacks
$0
YoY-100.0%

Sylvamo Corporation repurchased no shares in Q2 2026. This represents a decrease of 100.0% from the same quarter a year earlier.

Capital Expenditures
$61.0M
YoY-7.6%
QoQ+24.5%

Sylvamo Corporation invested $61.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 7.6% from the same quarter a year earlier. Against the prior quarter it is up 24.5%.

R&D Spending

Not reported for Q2 2026.

SLVM Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SLVM quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$806.0M+1.5%$755.0M-8.0%$890.0M-8.2%$846.0M-12.3%$794.0M-14.9%$821.0M-9.3%$970.0M+0.6%$965.0M+7.6%
Cost of Revenue$674.0M+5.3%$630.0M-4.8%$690.0M-5.9%$624.0M-10.9%$640.0M-6.4%$662.0M-7.5%$733.0M-2.7%$700.0M+5.3%
Gross Profit$132.0M-14.3%$125.0M-21.4%$200.0M-15.6%$222.0M-16.2%$154.0M-38.2%$159.0M-15.9%$237.0M+12.3%$265.0M+14.2%
SG&A Expenses$69.0M-4.2%$73.0M0.0%$68.0M-16.0%$68.0M-8.1%$72.0M-12.2%$73.0M-1.4%$81.0M-15.6%$74.0M-16.9%
Operating Income$14.0M-53.3%-$15.0M-134.1%$79.0M-27.5%$98.0M-34.7%$30.0M-75.4%$44.0M-38.9%$109.0M$150.0M
EBITDA$57.0M-24.0%$26.0M-69.0%$124.0M-19.0%$147.0M-22.2%$75.0M-52.8%$84.0M-24.3%$153.0M$189.0M
Interest Expense$15.0M+25.0%$12.0M0.0%$13.0M+18.2%$12.0M-36.8%$12.0M-7.7%$12.0M-14.3%$11.0M-26.7%$19.0M+26.7%
Income Tax$12.0M+140.0%-$3.0M-150.0%$25.0M+31.6%$31.0M-16.2%$5.0M-83.3%$6.0M-64.7%$19.0M+5.6%$37.0M+12.1%
Net Income-$11.0M-173.3%-$3.0M-111.1%$33.0M-59.3%$57.0M-40.0%$15.0M-81.9%$27.0M-37.2%$81.0M+65.3%$95.0M+63.8%
EPS (Basic)-$0.28-175.7%-$0.08-112.1%$0.84-57.6%$1.43-38.4%$0.37-81.7%$0.66-36.5%$1.98+66.4%$2.32+66.9%
EPS (Diluted)-$0.28-175.7%-$0.08-112.3%$0.82-57.3%$1.41-37.9%$0.37-81.3%$0.65-36.3%$1.92+65.5%$2.27+65.7%
Diluted Shares (Avg)40M-3.2%40M-4.6%N/A40M-3.8%41M-1.9%42M-1.4%N/A42M-1.2%

Not reported in any period shown, so not listed: R&D Expenses.

SLVM Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SLVM quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$2.9B+4.1%$2.8B+2.6%$2.8B+6.1%$2.7B-5.5%$2.8B+2.7%$2.8B+6.1%$2.6B-9.3%$2.9B+2.7%
Current Assets$1.1B+13.3%$1.1B+8.5%$1.1B+1.2%$990.0M-19.4%$977.0M-11.2%$1.0B-9.3%$1.1B-10.9%$1.2B+3.6%
Cash & Equivalents$123.0M+8.8%$130.0M-15.6%$135.0M-34.1%$94.0M-69.5%$113.0M-44.9%$154.0M-26.3%$205.0M-26.8%$308.0M+21.3%
Short-Term Investments$64.0M-8.6%$76.0M+15.2%$63.0M-39.4%$52.0M-68.7%$70.0M+2.9%$66.0M-4.3%$104.0M-4.6%$166.0M+80.4%
Inventory$503.0M+27.0%$483.0M+29.8%$418.0M+15.8%$434.0M+3.1%$396.0M-3.9%$372.0M-8.6%$361.0M-10.6%$421.0M-7.7%
Accounts Receivable$342.0M-4.2%$352.0M-9.5%$399.0M-0.7%$369.0M-10.2%$357.0M-7.8%$389.0M-1.0%$402.0M-0.5%$411.0M+2.0%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$121.0M-4.0%$121.0M+1.7%$114.0M+2.7%$128.0M+2.4%$126.0M+4.1%$119.0M-11.2%$111.0M-20.1%$125.0M-6.7%
Total Liabilities$1.9B+6.4%$1.9B0.0%$1.8B+2.3%$1.7B-10.3%$1.8B-3.1%$1.9B+8.2%$1.8B-10.9%$1.9B-1.3%
Current Liabilities$752.0M+18.4%$758.0M+23.1%$716.0M+5.0%$653.0M-8.5%$635.0M-2.9%$616.0M-5.1%$682.0M-1.9%$714.0M+5.9%
Non-Current Liabilities$1.2B-0.1%$1.1B-11.5%$1.1B+0.6%$1.1B-11.3%$1.2B-3.1%$1.2B+16.2%$1.1B-15.8%$1.2B-5.1%
Long-Term Debt$843.0M+9.9%$766.0M-3.5%$763.0M-2.4%$778.0M-11.9%$767.0M-14.2%$794.0M-13.8%$782.0M-16.0%$883.0M-6.7%
Total Equity$955.0M-0.4%$979.0M+7.8%$966.0M+14.0%$977.0M+4.3%$959.0M+15.5%$908.0M+2.1%$847.0M-6.0%$937.0M+12.1%
Retained Earnings$2.5B+0.2%$2.5B+1.2%$2.5B+2.4%$2.5B+4.4%$2.5B+6.2%$2.5B+9.3%$2.5B+10.5%$2.4B+9.5%

SLVM Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SLVM quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$38.0M-40.6%-$10.0M-143.5%$94.0M-42.7%$87.0M-46.6%$64.0M-44.3%$23.0M-14.8%$164.0M-1.8%$163.0M-17.3%
Depreciation & Amortization$43.0M-4.4%$41.0M+2.5%$45.0M+2.3%$49.0M+25.6%$45.0M+21.6%$40.0M+2.6%$44.0M+15.8%$39.0M+8.3%
Stock-Based Compensation$3.0M-57.1%$3.0M-50.0%N/A$4.0M-20.0%$7.0M+40.0%$6.0M-14.3%N/A$5.0M-16.7%
Capital Expenditures$61.0M-7.6%$49.0M+2.1%$56.0M-12.5%$54.0M+22.7%$66.0M+24.5%$48.0M-20.0%$64.0M$44.0M
Free Cash Flow-$23.0M-1050.0%-$59.0M-136.0%$38.0M-62.0%$33.0M-72.3%-$2.0M-103.2%-$25.0M+24.2%$100.0M$119.0M
Investing Cash Flow-$60.0M+9.1%-$49.0M-2.1%-$56.0M+12.5%-$54.0M-22.7%-$66.0M-24.5%-$48.0M+20.0%-$64.0M-1.6%-$44.0M-4.8%
Financing Cash Flow$15.0M+133.3%$53.0M+271.0%$3.0M+101.5%-$52.0M-173.7%-$45.0M+25.0%-$31.0M+11.4%-$196.0M-122.7%-$19.0M+67.2%
Dividends Paid$18.0M0.0%$18.0M0.0%$18.0M-5.3%$19.0M+5.6%$18.0M+38.5%$18.0M+50.0%$19.0M-24.0%$18.0M+63.6%
Share Buybacks$0-100.0%$0-100.0%$0-100.0%$42.0M$20.0M-20.0%$20.0M+300.0%$39.0M+129.4%$0-100.0%

SLVM Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SLVM quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Gross Margin16.4%-3.0pp16.6%-2.8pp22.5%-2.0pp26.2%-1.2pp19.4%-7.3pp19.4%-1.5pp24.4%+2.5pp27.5%+1.6pp
Operating Margin1.7%-2.0pp-2.0%-7.4pp8.9%-2.4pp11.6%-4.0pp3.8%-9.3pp5.4%-2.6pp11.2%15.5%
Net Margin-1.4%-3.3pp-0.4%-3.7pp3.7%-4.6pp6.7%-3.1pp1.9%-7.0pp3.3%-1.5pp8.3%+3.3pp9.8%+3.4pp
Return on Equity-1.1%-2.7pp-0.3%-3.3pp3.4%-6.1pp5.8%-4.3pp1.6%-8.4pp3.0%-1.9pp9.6%+4.1pp10.1%+3.2pp
Return on Assets-0.4%-0.9pp-0.1%-1.1pp1.2%-1.9pp2.1%-1.2pp0.5%-2.5pp1.0%-0.7pp3.1%+1.4pp3.3%+1.2pp
Current Ratio1.47-0.1x1.45-0.2x1.50-0.1x1.52-0.2x1.54-0.1x1.64-0.1x1.56-0.2x1.720.0x
Debt-to-Equity0.88+0.1x0.78-0.1x0.79-0.1x0.80-0.1x0.80-0.3x0.87-0.2x0.92-0.1x0.94-0.2x
Asset Turnover0.280.0x0.270.0x0.32-0.1x0.310.0x0.29-0.1x0.30-0.1x0.370.0x0.340.0x
FCF Margin-2.9%-2.6pp-7.8%-4.8pp4.3%-6.0pp3.9%-8.4pp-0.3%-6.9pp-3.0%+0.6pp10.3%12.3%

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Sylvamo Corporation SLVM FY2025 $3.4B $132.0M 3.9% $1.4B 48/100
Magnera Corporation MAGN FY2025 $3.2B -$159.0M -5.0% $416.5M 42/100
Clearwater Paper Corporation CLW FY2025 $1.6B -$18.6M -1.2% $326.4M 36/100
Mercer International Inc MERC FY2025 $1.9B -$498K 0.0% $26.2M 24/100

Frequently Asked Questions

What is Sylvamo Corporation's annual revenue?

Sylvamo Corporation (SLVM) reported $3.4B in total revenue for fiscal year 2025. This represents a -11.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Sylvamo Corporation's revenue growing?

Sylvamo Corporation (SLVM) revenue declined by 11.2% year-over-year, from $3.8B to $3.4B in fiscal year 2025.

Is Sylvamo Corporation profitable?

Yes, Sylvamo Corporation (SLVM) reported a net income of $132.0M in fiscal year 2025, with a net profit margin of 3.9%.

Sylvamo Corporation (SLVM) reported diluted earnings per share of $3.24 for fiscal year 2025. This represents a -54.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Sylvamo Corporation (SLVM) had EBITDA of $430.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Sylvamo Corporation (SLVM) had $135.0M in cash and equivalents against $763.0M in long-term debt.

Sylvamo Corporation (SLVM) had a gross margin of 21.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Sylvamo Corporation (SLVM) had an operating margin of 7.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Sylvamo Corporation (SLVM) had a net profit margin of 3.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Sylvamo Corporation (SLVM) paid $1.80 per share in dividends during fiscal year 2025.

Sylvamo Corporation (SLVM) has a return on equity of 13.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Sylvamo Corporation (SLVM) generated $44.0M in free cash flow during fiscal year 2025. This represents a -82.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Sylvamo Corporation (SLVM) generated $268.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Sylvamo Corporation (SLVM) had $2.8B in total assets as of fiscal year 2025, including both current and long-term assets.

Sylvamo Corporation (SLVM) invested $224.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Sylvamo Corporation (SLVM) spent $82.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Sylvamo Corporation (SLVM) had 40M shares outstanding as of fiscal year 2025.

Sylvamo Corporation (SLVM) had a current ratio of 1.50 as of fiscal year 2025, which is generally considered healthy.

Sylvamo Corporation (SLVM) had a debt-to-equity ratio of 0.79 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Sylvamo Corporation (SLVM) had a return on assets of 4.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Sylvamo Corporation (SLVM) trades at 18.5x earnings, its market capitalization divided by net income of $76.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $1.4B as of Sep 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Sylvamo Corporation (SLVM) trades at 0.4x sales, its market capitalization divided by revenue of $3.3B revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.4B as of Sep 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Sylvamo Corporation (SLVM) has an Altman Z-Score of 3.41, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Sylvamo Corporation (SLVM) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Sylvamo Corporation (SLVM) has an earnings quality ratio of 2.03x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Sylvamo Corporation (SLVM) has an interest coverage ratio of 5.12x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Sylvamo Corporation (SLVM) scores 48 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top